EN | 中文
BVCF

BioVeda China Fund (BVCF) since 2005 has been dedicated to creating and developing innovative global Chinese Life Sciences companies to benefit the health and wealth of the World.


BVCF has attracted global institutional financial and strategic investors to achieve this goal.


INVESTMENT STRATEGY

Grasp on opportunities and help place China to build global life science giants in the next few decades.


Forward-looking investment strategy based on keen insight into technology, policy and the market opportunities with a seasoned investment team.

NEWS
18
Oct
2022
BVCF Portfolio | DiaCarta to Become a Publicly Listed Company Through Merger with HH&L Acquisition Co.
5
Nov
2021
Cellenkos® Inc. Secures $15 Million Series A Financing to Accelerate the Development of Transformation Cell-Based Therapies
More